3D生物打印技术公司Aspect Biosystems建立的目的是对患者护理产生“有意义的影响”。该公司的目的是按需创建人体组织，并且已经开发了许多解决方案来帮助研究水平的生物制造。
Now, Aspect has earned the support of Canadian non-profit organization基因组British Columbia。总体而言，BC Genome已投资了100万美元，以进一步推进公司的商业化计划。并开发其3D生物打印平台。
“基因组BC在加速方面发挥了重要作用不列颠哥伦比亚省最有前途的生活科学创新，我们很高兴获得他们的支持。”
“借助这一额外的融资，我们正在进一步提高满足关键商业需求的能力，并在我们努力促进人类组织的努力时继续我们的快速增长。”
3D打印组织按需
Aspect’s core technology is the Lab-on-a-Printer™ platform. A play on实验室片研究设备，Lab-on-a-printer™本质上是由微型流畅驱动的3D生物生产商。
Each printhead in the Lab-on-a-Printer™ contains multiple, microscopic channels for the redirection of fluids, or inks. A unique technology, this platform enables the layering of multiple cell types to create 3D tissue structures.
One example of Lab-on-a-Printer™ application is Aspect’s 3DBioRing™ tissue, capable of mimicking the contraction and relaxation of human muscle.
“While we’re printing, we can switch between materials all in real-time,” explains Mohamed, “We can really start to create very intricate compositions and structures that are necessary to truly recreate what’s happening inside our body.”
大量的牵引力
Since its foundation in 2013, Aspect Biosystems has undertaken a a number of reputable projects within the industry, including acollaboration with the Fraunhofer institute for Toxicology and Experimental Medicine。
2017年，制药巨头Johnson＆Johnson与Factex Biosystems建立了合作伙伴关系，并发起了一个项目，以创建软骨以治疗膝盖受伤。最近，J＆J也共同进行了a specialist 3D bioprinting facilityat都柏林三一学院在爱尔兰。
Of the recent investment Dr.托尼·布鲁克斯, Chief Financial Officer and Vice President pf Entrepreneurship and Commercialization at Genome BC, said, “Aspect has shown significant commercial traction in a very short period of time and we are pleased to support their continued growth.”
For all the latest news in medical, dental, aerospace and automotive,subscribe to the3D打印行业newsletter， 跟着我们推特and like us onFacebook。
Our3D打印作业服务现已直播。必威官网登陆立即发布工作或在3D打印中推进您的职业生涯。
特色图显示了3D生物打印气道组织。通过方面生物系统的照片
